Proton therapy and concurrent chemotherapy may reduce bone marrow toxicity in advanced lung cancer

Posted by admin December 23rd, 2008

First study to examine the benefits of proton therapy versus standard treatment for lung cancer

CHICAGO – Patients treated for locally advanced non-small cell lung cancer who receive chemotherapy and proton beam therapy have fewer instances of bone marrow toxicity than patients who receive the standard treatment of intensity-modulated radiation (IMRT) and concurrent chemotherapy, sildenafil medicine according to researchers from The University of Texas M. D. Anderson Cancer Center.
Read Full Article

Tags: , ,